Clinical Radiology
Volume 64, Issue 1 , Pages 22-29 , January 2009

Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging

  • C.-T. Chou

      Affiliations

    • Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University
    • Department of Radiology, Chang-Hua Christian Hospital, Erlin Branch
    • ,
  • R.-C. Chen

      Affiliations

    • Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University
    • Department of Radiology, Taipei City Hospital, Renai Branch, Taiwan
    • Corresponding Author InformationGuarantor and correspondent: R.-C. Chen, Department of Radiology, Taipei City Hospital, Renai Branch, No. 10, Sec 4, Renai Road, Taipei 106, Taiwan. Tel.: +886 2 27093600x5103; fax: +886 2 27040013.
    • ,
  • W.-T. Chen

      Affiliations

    • Department of Radiology, Taipei City Hospital, Renai Branch, Taiwan
    • ,
  • J.-M. Lii

      Affiliations

    • Department of Radiology, Taipei City Hospital, Renai Branch, Taiwan

Received 18 March 2008 ,Revised 18 June 2008 ,Accepted 11 July 2008.

References 

  1. Szklaruk J, Silverman PM, Charnsangavej C. Imaging in the diagnosis, staging, treatment and surveillance of hepatocellular carcinoma. AJR Am J Roentgenol. 2003;180:441–454
  2. Noone TC, Semmelka RC, Chaney DM, et al. Abdominal imaging studies; comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging. 2004;22:19–24
  3. Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol. 2006;58:200–216
  4. Kanematsu M, Matsuo M, Yamada Y, et al. Perilesional hyperintense rim of malignant hepatic tumours on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging. 2003;18:40–48
  5. Koushima Y, Ebara M, Fukuda H, et al. Small hepatocellular carcinoma: assessment with T1-weighted spin-echo magnetic resonance imaging with and without fat suppression. Eur J Radiol. 2002;41:34–41
  6. Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology. 2000;32:205–212
  7. Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol. 2007;17:2969–2982
  8. Landis JR, Koch GG. The measurement of observer agreement for categrorical data. Biometrics. 1977;33:159–174
  9. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  10. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology. 2000;217:152–158
  11. Poeckler-Schoeniger C, Koepke J, Gueckel F, et al. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imaging. 1999;17:383–392
  12. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology. 2005;237:170–180
  13. Tanimoto A, Wakabayashi G, Shinmoto H, et al. The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells. J Magn Reson Imaging. 2005;21:230–236
  14. Macarini L, Marini S, Murrone M, et al. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis. Radiol Med. 2004;108:92–106
  15. Lee JM, Kim CS, Youk JH, et al. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Korean J Radiol. 2003;4:9–18
  16. Oswald P, Clement O, Chambon C, et al. Liver positive enhancement after injection of superparamagnetic nanoparticles: respective role of circulating and uptaken particles. Magn Reson Imaging. 1997;15:1025–1031
  17. Hamm B, Staks T, Taupitz M. SHU 555A. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging. Invest Radiol. 1994;29(Suppl. 2):S87–S89
  18. Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging. 1994;4:659–668
  19. Kim JH, Kim MJ, Suh SH, et al. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. J Magn Reson Imaging. 2002;15:573–583
  20. Van Beers BE, Gallez B, Pringot J. Contrast-enhanced MR imaging of the liver. Radiology. 1997;203:297–306
  21. Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology. 1999;30:889–893
  22. Kim YK, Kwak HS, Kim CS, et al. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology. 2006;238:531–541

PII: S0009-9260(08)00323-1

doi: 10.1016/j.crad.2008.07.010

Clinical Radiology
Volume 64, Issue 1 , Pages 22-29 , January 2009

Article Tools

* Image Usage & Resolution